Last reviewed · How we verify
NCT05296655
Kazakh Version of Reflux Symptom Index
trial testing Reflux Symptom Index Inventory (diagnostic survey) in Laryngopharyngeal Reflux Symptoms in 248 participants. Completed in 16 February 2022.
15 February 2022
Quick facts
| Lead sponsor | Kazakh Medical University of Continuing Education |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 248 |
| Start date | 1 March 2020 |
| Primary completion | 15 February 2022 |
| Estimated completion | 16 February 2022 |
| Sites | 2 locations across Kazakhstan |
Drugs / interventions tested
- Reflux Symptom Index Inventory (diagnostic survey)
- Reflux finding score
Conditions studied
- Laryngopharyngeal Reflux Symptoms — all drugs for Laryngopharyngeal Reflux Symptoms →
- Laryngopharyngitis Chronic — all drugs for Laryngopharyngitis Chronic →
- Gastro Esophageal Reflux Disease — all drugs for Gastro Esophageal Reflux Disease →
Sponsor
Kazakh Medical University of Continuing Education
Who can join
Adults 18 to 74, any sex, with Laryngopharyngeal Reflux Symptoms or Laryngopharyngitis Chronic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Reflux symptoms index (RSI) were developed to identify a clinical index of suspicion for laryngopharyngeal reflux (LPR) in patients with ear, nose, and throat symptoms. RSI is an efficient diagnostic tool for LPR/ It is easy to use, even for those who know little about LPR. It does not require special equipment or examinations and is inexpensive. Thus, it can be considered highly efficient and cost-effective. The study will focus on translating and testing the RSI into Kazakh language and comparing its results in healthy people and people with laryngopharyngeal reflux.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05296655
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Kazakh Medical University of Continuing Education trials
Trials by the same sponsor.
- NCT05011409 — Prevalence of Depression and Anxiety Among Breast Cancer Patients · completed
- NCT04771221 — Method of Early Diagnosis of Laryngopharyngeal Reflux · NA · completed
- NCT04630327 — Validation of the Russian and Kazakh Versions of the Beck Depression Inventory and Beck Anxiety Inventory · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05296655 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kazakh Medical University of Continuing Education
- Last refreshed: 23 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05296655.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing